Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans
Sponsor: VA Office of Research and Development
Summary
Veterans have numerous risk factors (e.g., PTSD, TBI, cerebrovascular problems) for later-life cognitive and functional decline. Evidence supports the effectiveness of strategy-based cognitive rehabilitation therapies, including compensatory cognitive training (CCT), for such decline. However, questions remain about the length of time that CCT-driven improvements in cognitive and everyday function last, and whether additional 'booster' training sessions could provide additional benefit to aging Veterans who previously underwent treatment. This study examines the long-term durability of CCT in Veterans aged 55+ and provides an opportunity to develop and pilot test a series of CCT booster sessions that can be personalized toward individual everyday functional goals.
Official title: Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans (AID-CCT)
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2023-07-01
Completion Date
2028-06-30
Last Updated
2025-08-13
Healthy Volunteers
No
Conditions
Interventions
Motivationally-Enhanced Compensatory Cognitive Training (ME-CCT) Booster Modules
ME-CCT is a traditionally a manualized group-based behavioral intervention (8 weeks, 2 hours per week) designed to improve cognitive and everyday functioning in patients with MCI. Our booster modules will be shortened and distilled from ME-CCT using the IM Adapt protocol (and thus will not be new information but rather 'reminder' content) for a personalized four-session sequence of booster training targeted toward specific everyday functional needs of individual participants.
Treatment As Usual
Treatment for MCI is generally managed by Primary Care or Neurology. Participants will continue to receive their usual care with their current providers. With no effective pharmacological treatment known for persons with MCI, providers tend to focus on encouraging a healthy lifestyle, prevention and management of modifiable risk factors for cognitive impairment, and treatment of behavioral and psychiatric symptoms.
Locations (1)
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States